跳至主要内容
临床试验/NL-OMON28458
NL-OMON28458招募中不适用

‘Tacrolimus and Azoles: effect of tacrolimus Formulation on drug-drug Interaction study’

MCG0 个研究点目标入组 48 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Age >18 years
  • -Lung, kidney, pancreas or heart transplant recipient
  • - Stable use of oral tacrolimus formulations Prograft/generic tacrolimus/Envarsus
  • -eGFR >20 ml/min
  • -Indication for antifungal therapy with oral voriconazole or fluconazole
  • -Written informed consent

排除标准

  • -Administration of mTOR inhibitors, cyclosporine or quadruple immunosuppression
  • -Pregnancy
  • -Concomitant use of drugs that have a pharmacokinetic interaction with tacrolimus
  • -Acute liver- or intestinal function impairment (liver function over 3 times the reference values; function impairment started in week before 1st study visit and/or expected to be instable for the next weeks)

研究者

发起方
MCG

相似试验